These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30866919)

  • 1. Genetic and epigenetic characteristics in ovarian tissues from polycystic ovary syndrome patients with irregular menstruation resemble those of ovarian cancer.
    Jiao J; Sagnelli M; Shi B; Fang Y; Shen Z; Tang T; Dong B; Li D; Wang X
    BMC Endocr Disord; 2019 Mar; 19(1):30. PubMed ID: 30866919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irregular menses predicts ovarian cancer: Prospective evidence from the Child Health and Development Studies.
    Cirillo PM; Wang ET; Cedars MI; Chen LM; Cohn BA
    Int J Cancer; 2016 Sep; 139(5):1009-17. PubMed ID: 27082375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylome profiling of granulosa cells reveals altered methylation in genes regulating vital ovarian functions in polycystic ovary syndrome.
    Sagvekar P; Kumar P; Mangoli V; Desai S; Mukherjee S
    Clin Epigenetics; 2019 Apr; 11(1):61. PubMed ID: 30975191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of epigenetic interactions between microRNA and DNA methylation associated with polycystic ovarian syndrome.
    Mao Z; Li T; Zhao H; Qin Y; Wang X; Kang Y
    J Hum Genet; 2021 Feb; 66(2):123-137. PubMed ID: 32759991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
    Kim JJ; Hwang KR; Chae SJ; Yoon SH; Choi YM
    Hum Reprod; 2020 Mar; 35(3):652-659. PubMed ID: 32211797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
    West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
    Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium.
    Harris HR; Babic A; Webb PM; Nagle CM; Jordan SJ; Risch HA; Rossing MA; Doherty JA; Goodman MT; Modugno F; Ness RB; Moysich KB; Kjær SK; Høgdall E; Jensen A; Schildkraut JM; Berchuck A; Cramer DW; Bandera EV; Wentzensen N; Kotsopoulos J; Narod SA; Phelan CM; McLaughlin JR; Anton-Culver H; Ziogas A; Pearce CL; Wu AH; Terry KL; ;
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):174-182. PubMed ID: 29141849
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epigenetics of polycystic ovary syndrome].
    Concha C F; Sir P T; Recabarren SE; Pérez B F
    Rev Med Chil; 2017 Jul; 145(7):907-915. PubMed ID: 29182200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome.
    Nilsson E; Benrick A; Kokosar M; Krook A; Lindgren E; Källman T; Martis MM; Højlund K; Ling C; Stener-Victorin E
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4465-4477. PubMed ID: 30113663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Marks in Polycystic Ovary Syndrome.
    Motta AB
    Curr Med Chem; 2020; 27(39):6727-6743. PubMed ID: 31580245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic Ovary Syndrome-Epigenetic Mechanisms and Aberrant MicroRNA.
    Ilie IR; Georgescu CE
    Adv Clin Chem; 2015; 71():25-45. PubMed ID: 26411410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylation of the LH/choriogonadotropin receptor promoter region is a potential mechanism underlying susceptibility to polycystic ovary syndrome.
    Wang P; Zhao H; Li T; Zhang W; Wu K; Li M; Bian Y; Liu H; Ning Y; Li G; Chen ZJ
    Endocrinology; 2014 Apr; 155(4):1445-52. PubMed ID: 24527662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome in adolescent girls.
    Baldauff NH; Witchel SF
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Young women with poor ovarian response exhibit epigenetic age acceleration based on evaluation of white blood cells using a DNA methylation-derived age prediction model.
    Hanson BM; Tao X; Zhan Y; Jenkins TG; Morin SJ; Scott RT; Seli EU
    Hum Reprod; 2020 Nov; 35(11):2579-2588. PubMed ID: 33049778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression.
    Wang YQ; Yan Q; Zhang JR; Li SD; Yang YX; Wan XP
    J Obstet Gynaecol Res; 2013 Feb; 39(2):549-54. PubMed ID: 23006047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation in the pathogenesis of polycystic ovary syndrome.
    Vázquez-Martínez ER; Gómez-Viais YI; García-Gómez E; Reyes-Mayoral C; Reyes-Muñoz E; Camacho-Arroyo I; Cerbón M
    Reproduction; 2019 Jul; 158(1):R27-R40. PubMed ID: 30959484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide methylation profiling in granulosa lutein cells of women with polycystic ovary syndrome (PCOS).
    Makrinou E; Drong AW; Christopoulos G; Lerner A; Chapa-Chorda I; Karaderi T; Lavery S; Hardy K; Lindgren CM; Franks S
    Mol Cell Endocrinol; 2020 Jan; 500():110611. PubMed ID: 31600550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causal pathways linking polycystic ovary syndrome to distinct breast cancer subtypes through mediator factors: a multivariable mendelian randomization analysis.
    Cao R; Chen L; Liu Y; Wang X; Ma R; Zhao Q; Du Y
    J Ovarian Res; 2023 Nov; 16(1):215. PubMed ID: 37957709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.